Horizon Therapeutics Aktie

Kaufen
Verkaufen
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Bei einem anderen Broker handeln Smartphone
KGV 51,34 Div. Rendite 0,00%

WKN A12B8E

ISIN IE00BQPVQZ61

Symbol HZNP


Horizon Therapeutics Aktie Analyse

14.08.19 Horizon Therapeutics Outperform BMO Capital Markets
15.11.18 Horizon Therapeutics Neutral Mizuho
10.08.18 Horizon Therapeutics Market Perform BMO Capital Markets
12.01.18 Horizon Therapeutics Buy Mizuho
16.06.17 Horizon Therapeutics Overweight Cantor Fitzgerald
09.05.17 Horizon Therapeutics Buy Stifel, Nicolaus & Co., Inc.
09.05.17 Horizon Therapeutics Neutral Mizuho
28.02.17 Horizon Therapeutics Buy Mizuho
16.12.16 Horizon Therapeutics Buy Mizuho
09.12.16 Horizon Therapeutics Neutral Mizuho
08.11.16 Horizon Therapeutics Buy Mizuho
31.10.16 Horizon Therapeutics Buy Mizuho
13.09.16 Horizon Therapeutics Buy Mizuho
10.05.16 Horizon Therapeutics Buy Mizuho
03.05.16 Horizon Therapeutics Buy Mizuho
14.12.15 Horizon Therapeutics Buy Mizuho
10.11.15 Horizon Therapeutics Buy Mizuho
09.10.15 Horizon Therapeutics Buy Mizuho
08.07.15 Horizon Therapeutics Buy Brean Capital
26.06.15 Horizon Therapeutics Buy UBS AG
11.05.15 Horizon Therapeutics Buy UBS AG
17.04.15 Horizon Therapeutics Buy Stifel, Nicolaus & Co., Inc.
31.03.15 Horizon Therapeutics Buy UBS AG
31.03.15 Horizon Therapeutics Buy Brean Capital
02.03.15 Horizon Therapeutics Buy Stifel, Nicolaus & Co., Inc.
02.03.15 Horizon Therapeutics Buy Brean Capital
08.01.15 Horizon Therapeutics Buy Brean Capital